Reactive Oxygen Species Scavenging Functional Hydrogel Delivers Procyanidins for the Treatment of Traumatic Brain Injury in Mice.
Xuyang HuangYongqing YeJianyong ZhangXuefeng ZhangHongwei MaYongkang ZhangXianhua FuJiaJia TangNing JiangYuhan HanHong-Mei LiuHonglin ChenPublished in: ACS applied materials & interfaces (2022)
Traumatic brain injury (TBI) is accompanied by the overload of reactive oxygen species (ROS), which can result in secondary brain injury. Although procyanidins (PCs) have a powerful free radical scavenging capability and have been widely studied in the treatment of TBI, conventional systemic drug therapy cannot make the drug reach the targeted area in the early stage of TBI and will cause systemic side effects because of the presence of the blood-brain barrier (BBB). To address this tissue, we designed and fabricated a ROS-scavenging functional hydrogel loaded PC (GelMA-PPS/PC) to deliver the drug by responding to the traumatic microenvironment. In situ injection of the GelMA-PPS/PC hydrogel effectively avoided the BBB and was directly applied to the surface of brain tissue to target the traumatic area. Hydrophobic poly(propylene sulfide) 60 (PPS 60 ), an ROS quencher and H 2 O 2 -responsive substance, was covalently bound to GelMA and exposed in response to the trauma microenvironment. At the same time, the H 2 O 2 response of PPS 60 further caused the structure of the hydrogel to degrade and release the encapsulated PC. Then PC could regulate the oxidative stress response in the cells and synergistically deplete ROS to play a neurotrophic protective role. This work suggests a novel method for the treatment of secondary brain injury by inhibiting the oxidative stress response after TBI.
Keyphrases
- traumatic brain injury
- reactive oxygen species
- brain injury
- drug delivery
- early stage
- cell death
- dna damage
- severe traumatic brain injury
- spinal cord injury
- stem cells
- cancer therapy
- wound healing
- emergency department
- hyaluronic acid
- white matter
- radiation therapy
- mesenchymal stem cells
- blood brain barrier
- mild traumatic brain injury
- replacement therapy
- combination therapy
- insulin resistance
- skeletal muscle
- cell therapy
- locally advanced
- rectal cancer